Loading...
XNAS
DH
Market cap85mUSD
Jul 09, Last price  
0.80USD
1D
-1.26%
1Q
-15.30%
IPO
-98.30%
Name

Definitive Healthcare Corp

Chart & Performance

D1W1MN
XNAS:DH chart
P/E
P/S
0.35
EPS
Div Yield, %
Shrs. gr., 5y
1.91%
Rev. gr., 5y
15.34%
Revenues
242m
-4.24%
85,503,000118,317,000166,154,000222,653,000251,415,000252,202,000241,521,000
Net income
-139m
L-66.37%
-36,398,000-52,598,000-51,908,000-7,222,000-202,388,000-413,124,000-138,932,000
CFO
54m
-7.59%
21,594,00023,217,00025,212,00035,579,00041,190,00058,196,00053,777,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
IPO date
Sep 15, 2021
Employees
946
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT